Announcements Trials
Browse Landscape

Status

Completed 981Recruiting 419Terminated 236Unknown 223Active not recruiting 161Withdrawn 95Not yet recruiting 79Suspended 9No longer available 8Enrolling by invitation 8Available 3Approved for marketing 1

Sponsor Class

INDUSTRY 8OTHER 3

Study Type

Expanded_access 3

Sponsor

Cancer Type

CNS 7Tumor-Agnostic 5Other hematologic neoplasm 4Sarcoma 3Head & Neck 3Endocrine 3Thoracic 2Myeloid 2Gynecologic 2Genitourinary 2Gastrointestinal 2Breast 2Plasma cell 1NET 1Lymphoid 1Classical hematology 1

Conditions

Osteosarcoma 2Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Liposarcoma 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Fibrosarcoma 1Chordoma 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenoma, Islet Cell 1

Interventions

mifamurtide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Available × OTHER × Sarcoma × Clear all
NCT04571229 2026-05-11

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Memorial Sloan Kettering Cancer Center

Available
Sarcoma

Osteosarcoma

NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Aveni Foundation

Available
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡